We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M Turnover 59%
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$702M
AUM Growth
-$200M
Cap. Flow
-$80.1M
Cap. Flow %
-11.41%
Top 10 Hldgs %
28.8%
Holding
103
New
24
Increased
13
Reduced
18
Closed
33
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.5 years

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$19.1M
2
AMD icon
Advanced Micro Devices
AMD
+$18M
3
FTAI icon
FTAI Aviation
FTAI
+$15.3M
4
APG icon
APi Group
APG
+$14.9M
5
CYTK icon
Cytokinetics
CYTK
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 24.98%
2 Miscellaneous 16.64%
3 Industrials 15.4%
4 Technology 11.23%
5 Consumer Discretionary 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TNDM icon
1
Tandem Diabetes Care
TNDM
$1.15B
$28.5M 4.06%
790,547
+260,547
+49% +$8.81M
2023 Q4
4 quarters
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.22B
$26.4M 3.77%
2,000,000
+1,000,000
+100% +$17.1M
2023 Q4
4 quarters
PRAX icon
3
Praxis Precision Medicines
PRAX
$6.93B
$23.3M 3.32%
303,000
-65,000
-18% -$4.7M
2021 Q2
14 quarters
IWM icon
4
PUT
iShares Russell 2000 ETF
IWM
$77.5B
$22.1M 3.15%
+100,000
New +$22.8M
2024 Q4
0 quarters
THC icon
5
Tenet Healthcare
THC
$22.2B
$19.1M 2.73%
151,700
-14,522
-9% -$2.16M
2023 Q4
4 quarters
CRH icon
6
CRH
CRH
$54.8B
$17.1M 2.44%
185,000
– –
2024 Q1
3 quarters
ECG icon
7
Everus Construction Group
ECG
$5.7B
$17.1M 2.44%
+260,000
New +$16.4M
2024 Q4
0 quarters
TAP icon
8
Molson Coors Class B
TAP
$7.28B
$16.5M 2.35%
288,200
– –
2023 Q1
7 quarters
ONON icon
9
On Holding
ONON
$11.8B
$16.4M 2.34%
300,000
+20,000
+7% +$1.06M
2024 Q3
1 quarter
INSM icon
10
Insmed
INSM
$21.7B
$15.5M 2.21%
225,000
-175,000
-44% -$12.6M
2023 Q4
4 quarters
MMM icon
11
3M
MMM
$85.3B
$14.8M 2.11%
115,000
-25,000
-18% -$3.28M
2024 Q1
3 quarters
TSM icon
12
TSMC
TSM
$2.19T
$14.8M 2.11%
75,000
+10,000
+15% +$1.94M
2024 Q1
3 quarters
IP icon
13
International Paper
IP
$18.1B
$14.8M 2.11%
275,000
-25,000
-8% -$1.34M
2024 Q2
2 quarters
SPY icon
14
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$14.7M 2.09%
25,000
-125,000
-83% -$73.6M
2024 Q3
1 quarter
HEI icon
15
HEICO Corp
HEI
$43.1B
$14.3M 2.03%
60,000
+5,000
+9% +$1.3M
2023 Q1
7 quarters
CRL icon
16
Charles River Laboratories
CRL
$14.6B
$14M 1.99%
75,700
+1,600
+2% +$308K
2024 Q2
2 quarters
SAIA icon
17
Saia
SAIA
$9.08B
$13.7M 1.95%
30,000
-2,500
-8% -$1.24M
2024 Q3
1 quarter
CART icon
18
Maplebear
CART
$12.1B
$13.3M 1.89%
+320,000
New +$13.9M
2024 Q4
0 quarters
META icon
19
Meta Platforms (Facebook)
META
$1.88T
$13.2M 1.88%
22,500
– –
2023 Q1
7 quarters
BX icon
20
PUT
Blackstone
BX
$87.1B
$12.9M 1.84%
+75,000
New +$13.1M
2024 Q4
0 quarters
IMAX icon
21
IMAX
IMAX
$2.83B
$12.8M 1.82%
500,000
+200,000
+67% +$4.7M
2024 Q3
1 quarter
BOOT icon
22
Boot Barn
BOOT
$3.65B
$12.7M 1.8%
+83,400
New +$12.3M
2024 Q4
0 quarters
PWR icon
23
Quanta Services
PWR
$96.6B
$12.6M 1.8%
40,000
– –
2022 Q4
8 quarters
WDC icon
24
Western Digital
WDC
$133B
$12.5M 1.78%
+277,830
New +$14M
2024 Q4
0 quarters
CW icon
25
Curtiss-Wright
CW
$18.5B
$12.4M 1.77%
35,000
– –
2023 Q2
6 quarters

Similar funds

Kingdon Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Kingdon Capital Management held 103 positions worth $702M, down 22% from $902M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Kingdon Capital Management withdrew a net $80.1M in Q4 2024, closing 33 positions and reducing 18 holdings. Its most notable exit was Abbott, an estimated $19.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Kingdon Capital Management opened a new position in Everus Construction Group worth $17.1M.

  • Kingdon Capital Management's largest Q4 2024 buy was Everus Construction Group: 260,000 shares worth $17.1M.
  • Kingdon Capital Management added most to Syndax Pharmaceuticals in Q4 2024, an estimated $17.1M increase.
  • Kingdon Capital Management's biggest Q4 2024 reduction was Insmed, cutting an estimated $12.6M.
  • Kingdon Capital Management fully exited Abbott in Q4 2024, selling an estimated $19.1M.
  • Kingdon Capital Management's ten largest holdings make up 29% of its $702M portfolio in Q4 2024.
  • Kingdon Capital Management opened 24 new positions and closed 33 in Q4 2024.
  • Kingdon Capital Management's portfolio value fell 22% quarter-over-quarter to $702M.

Based on Kingdon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.